Dr. Duker is available for appointments in Boston.

Jay S. Duker, MD

Director, New England Eye Center

Vitreoretinal Diseases & Surgery Service

 

Medical School

Jefferson Medical College of Thomas Jefferson University

Residency

Wills Eye Hospital

Fellowship

Vitreoretinal Diseases and Surgery and Intraocular Tumors, Wills Eye Hospital

Academic Appointment

Professor and Chair of Ophthalmology, Tufts University School of Medicine

Jay S. Duker, MD is Professor and Chairman of Ophthalmology at the Tufts Medical Center and Tufts University School of Medicine in Boston, Massachusetts. Through his varied ophthalmology-related activities over three decades of practice, he has developed a local, regional, national, and international reputation as a highly successful clinician, surgeon, diagnostician, educator, researcher, administrator and entrepreneur.

A practicing ophthalmic physician and surgeon, Dr. Duker’s specializes in diseases of the posterior segment of the eye including age related macular degeneration (AMD), diabetic retinopathy, and retinal vascular diseases, as well as surgical macular diseases such as epiretinal membrane and macular hole. He also see patients with uveitis and intraocular tumors. He also has a particular interest in rare and unusual retinal disorders, especially those connected to systemic disease.

Dr. Duker received his A.B. degree cum laude from Harvard University in 1980 and his M.D degree magna cum laude from Jefferson Medical College in 1984 where he was elected to Alpha Omega Alpha Honor Society. He completed an internal medicine internship at the Beth Israel Hospital in Boston followed by a residency in ophthalmology at the Wills Eye Hospital where he selected to be Chief Resident. This was followed by a two year medical and surgical fellowship in retinal diseases and intraocular tumors at Wills Eye Hospital.

Following fellowship, Dr. Duker entered practice with the Schepens Retina Associates in Boston in 1990. In 1992, he was recruited to become the Chief of the Retina Service at the New England Eye Center at Tufts Medical Center. He became acting Chairman of the Department of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine in 2001 and was appointed full time Chairman in 2003, a position he continues to hold.

Dr. Duker serves as the Director of the New England Eye Center (NEEC), an academic, multi-specialty eye care group with 27 full time ophthalmologists and nearly 200 employees. NEEC has its main office at Tufts Medical Center in Boston, MA as well as seven satellites offices in Eastern Massachusetts (Mt. Auburn Hospital, Steward St. Elizabeth’s Medical Center, Brookline, Wellesley, Framingham, Watertown, and Leominster). Almost 100,000 patient encounters per year are performed in its facilities and NEEC has annual revenues in excess of     $24 million, making it among the largest academic ophthalmology practices in the United States.

Dr. Duker was the principle founder and a current member of the board of directors of Surgisite Boston, an ophthalmology-only, out-patient surgery center in Waltham, MA that opened in 2006. Surgisite Boston represents a unique joint venture between the Tufts academic ophthalmology department and community ophthalmologists. Together, this unique melding of private and academic practices initiated by Dr. Duker rapidly evolved into the busiest ophthalmic surgery center in Massachusetts on the principle of "quality first". Surgisite Boston performed nearly 10,000 intraocular surgeries during 2014.

As Chairman of Ophthalmology for Tufts Medical Center, Dr. Duker has the responsibility for managing the hospital's Eye Clinic, the second busiest out-patient service in the hospital. Along with his administrative role with the vision care practice, in his dual role as Chairman of Ophthalmology for Tufts University School of Medicine, he is responsible for the oversight of the academic mission of the department: teaching of medical students, residents, fellows and practicing eye care providers and cultivation of vision research.

With regard to academic achievement, under Dr. Duker’s leadership the Tufts Department of Ophthalmology’s research program has been active and productive, including both bench research vision scientists as well as clinical research specialists. The department and its individual researchers receive generous support from an unrestricted grant from Research to Prevent Blindness (RPB), as well as grants from the Foundation for Fighting Blindness (FFB), the Massachusetts Lions Clubs, and the New England Cornea Fund. There are four National Eye Institute (NEI) funded researchers within the department and another 10 NEI-supported vision researchers based in other Tufts University departments. An umbrella organization, the Tufts Center of Vision Research (TCVR) ties all these researchers together. Important clinical innovations that have come from the work of NEEC investigators include optical coherence tomography (OCT), intravitreal triamcinolone for diabetic macular edema, topical lidocaine gel for ophthalmic procedures, and the discovery of several unique genes linked to age related macular degeneration.

His personal research interests include novel imaging techniques of the eye, especially optical coherence tomography (OCT), drug delivery to the posterior segment, retinal vascular disorders and posterior segment uveitis. Over the past two decades, he has been instrumental in discovering clinical applications of OCT technology. He was one of the first to investigate the use of a long-acting ganciclovir implant for the treatment of cytomegalovirus (CMV) retinitis. He has served as principle investigator or co-investigator in two dozen industry-sponsored and NEI-sponsored multi-centered trials.

Dr. Duker has approximately 180 papers published in peer-reviewed journals. His manuscripts have appeared in high impact journals and one of them has been among the top 10 referenced ophthalmology research papers over the past five years. As a result, he is currently recognized as the sixth most influential author in ophthalmology in the world by Microsoft's Academic Search (http://academic.research.microsoft.com/?SearchDomain=6&SubDomain=18&entitytype=2 )

He serves on the editorial boards of three journals: OSLI Retina, Retina Cases and Brief Reports, and Investigative Ophthalmology and Visual Sciences.  He served as a reviewer for a myriad of journals including the New England Journal of Medicine, JAMA Ophthalmology, Ophthalmology, American Journal of Ophthalmology, and Retina. He served as an examiner for the American Board of Ophthalmology from 1999 to 2005.

Dr. Duker has received many awards including the Heed Ophthalmic Foundation Fellowship, both the Honor Award and the Senior Honor Award from the American Academy of Ophthalmology (AAO), and the American Society of Retinal Specialists (ASRS). He has been named one of the best doctors in Boston by Boston Magazine for 8 years in a row. Castle Connolly recognize him as one of the top doctors in the United States and US News and World report rank him among the top 100 ophthalmologists in the United States.

Dr. Duker’s commitment to medical education includes direct involvement in the publishing of a number of textbooks. He serves as a lead editor for Yanoff and Duker’s Ophthalmology, which is currently in its fourth edition.  This award-winning textbook has been one of the best-selling titles in visual sciences over the past decade. In addition, Dr. Duker has written or edited several other books including A Handbook of OCT, Optical Coherence Tomography (3rd edition), Rapid Diagnosis in Ophthalmology, and the Atlas of Ophthalmic Surgery (2nd edition). He has two other books currently in production: Current Management of Age-Related Macular Degeneration and A Handbook of Retinal Diseases. Along with his work as a writer and editor of textbooks, he has authored 27 individual textbook chapters. He serves on Elseveir’s Clinical Key editorial board.

Under his direction as chairman, 56 ophthalmology residents have been trained and are currently in practice all across the United States. Additionally another 84 fellows in ophthalmology have been graduated during his leadership span, including 28 surgical retina fellows and 10 medical retinal fellows.

Dr. Duker has been active in professional organizations including the American Academy of Ophthalmology, the American Society of Retina Specialists, The New England Ophthalmology Society, The International Society of Sports Vision, The Massachusetts Society of Eye Physicians and Surgeons, the Society of Heed Fellows, The Association for Research in Vision and Ophthalmology.

He has served as board member of the Massachusetts Society of Eye Physicians and Surgeons, Baystate Health Care, the Boston Aid to the Blind, Tufts Medical Center and the Tufts Medical Center Physicians Organization.

Dr. Duker has given hundreds of lectures locally, regionally, and nationally. In addition, he is a widely sought-after speaker for international meetings. Over his career he has delivered lectures in Canada, Mexico, Colombia, Brazil, England, Spain, Germany, Italy, Switzerland, Israel, Saudi Arabia, and Ghana. He has been an invited Grand Rounds speaker at 12 institutions and has delivered two named lectures.

Since 1993, Dr. Duker has helped to organize, plan and moderate the Hawaiian Eye Retina Meeting, one of the largest non-society sponsored retina meetings in the world.

Dr. Duker was appointed a Director of Eleven Biotherapeutics, a publically-traded clinical stage biotech company that is developing protein therapeutics for the eye. He has served or currently serves as a consultant for many companies including Astra Zeneca, Ophthotech, EyeNetra, Genentech/Roche, Alcon/Novartis, CoDa, Merck, EMD/Serono, QLT Pharmaceuticals, Nicox, Optos, Panoptica, Constellation Therapeutics, Thrombogenics, Topcon, OptoVue, Carl Zeiss Meditech, Regeneron, JP Morgan, Cowan and Associates, Gerson Lehman Group, Third Rock Ventures, and McKinsey Consultants.

Along with being the founder of a highly successful ophthalmic ambulatory surgery center, Dr. Duker is founder and currently involved in three other start-up companies:  Hemera Biosciences, a pre-clinical biotech company developing treatments of eye disease through complement inhibition, Scalable Diagnostics which is building a device to do automated diabetic retinopathy screening, and the Boston Image Reading Center (BIRC).

 

Contact Information

Dr. Duker's Office: 617-636-4677
Fax: 617-636-4866
Patient Appointments: Boston: 617-636-4604

 

 

Jay S. Duker, MD; Director, New England Eye Center